Journal Of Clinical Trials Serving For 9 Years To The World’s Research On Clinical Evaluations To The Scientific Community


On behalf of the Journal of Clinical Trials as Editor-in-Chief, working to make concise overview of the history of clinical trials on scientific discoveries, and research on the effectiveness of various psychotherapies in general practice and for treatment of specific common disorders. It is my distinct honour and privilege to inform you that, it’s been nine long years we have started the Journal, now we are celebrating the 9th Anniversary and we are privileged to welcome Diagnostic Society to our journal. As Editor-In-Chief it is my great pleasure and honour to welcome you to the Journal of Clinical Trials.

Journal of Clinical Trials is an Open Access peer reviewed, online publishing journal, which aims to publish scholarly and quality papers in the significant areas of current Clinical trials.

Clinical Trials are research studies to search whether a medical strategy, treatment, or device is safe and effective for humans, also may explains which medical approaches works best for certain illnesses or groups of people. This peer reviewed journal covers a broad aspect of Clinical trials, Clinical practice guidelines, Clinical research methodologies, Pre-clinical trials, Randomized trials, Protocols and other related topics justifying the title of the Journal. 

Journal of Clinical Trials studies follows scientific standards. These standards may protect patients and also helps in producing reliable study results. Clinical trials are one of the final stages of a long and careful research process. For safety purposes, clinical trials start with small groups of patients to find out whether a new approach causes any harm. In later phases of clinical trials, researchers learn more about the new approach's risks and benefits. Realizing the importance of this field, Omics Publishers has organized a prestigious conference on 13th Global Pharmacovigilance and clinical trials summit which was held on Mar 28-29, 2019, Osaka, Japan under the theme Pharmacovigilance.

The conference includes around 150 Abstracts and 100 Keynote speakers have given their valuable words. The meet has provided a great scope for interaction of professionals including in addition to clinical experts and top-level pathologists and scientists from around the globe, on a single platform.

Eminent speakers lined up to share valuable include Dr. Jacob Joseph, Ujwala Vilas Salvi and many more.



Managing Editor
Journal of Clinical Trials